Bosh sahifaME • NASDAQ
add
23andMe Holding Co.
3,11 $
Seans yopilganidan keyin:(3,54%)+0,11
3,22 $
Yopilgan:22-noy, 18:26:25 (GMT-5) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
3,23 $
Kunlik diapazon
2,99 $ - 3,21 $
Yillik diapazon
2,66 $ - 20,20 $
Bozor kapitalizatsiyasi
74,94 mln USD
Oʻrtacha hajm
404,88 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(USD) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 44,07 mln | -11,86% |
Joriy xarajat | 81,33 mln | -17,18% |
Sof foyda | -59,10 mln | 21,48% |
Sof foyda marjasi | -134,11 | 10,91% |
Har bir ulushga tushum | — | — |
EBITDA | -54,96 mln | 21,06% |
Amaldagi soliq stavkasi | 0,07% | — |
Balans
Jami aktivlari
Jami passivlari
(USD) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 126,60 mln | -50,62% |
Jami aktivlari | 318,94 mln | -60,19% |
Jami passivlari | 217,01 mln | 23,31% |
Umumiy kapital | 101,93 mln | — |
Tarqatilgan aksiyalar | 26,12 mln | — |
Narxi/balansdagi bahosi | 0,82 | — |
Aktivlardan daromad | -42,89% | — |
Kapitaldan daromad | -75,30% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(USD) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | -59,10 mln | 21,48% |
Operatsiyalardan naqd pul | -40,93 mln | 28,34% |
Sarmoyadan naqd pul | -2,70 mln | 2,63% |
Moliyadan naqd pul | 260,00 ming | -83,68% |
Naqd pulning sof oʻzgarishi | -43,37 mln | 25,18% |
Boʻsh pul | -12,82 mln | 59,90% |
Haqida
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Tashkil etilgan
apr 2006
Sayt
Xodimlar soni
571